New treatment approach for prostate cancer could stop resistance in its tracks
By inhibiting one enzyme, scientists from Sanford Burnham Prebys can kill prostate cancer cells when other treatments can’t. The discovery could help address the growing threat of treatment resistance in prostate cancer and also lead to improved treatments for other cancers, such as breast, skin and pancreas.
“This is the first time this enzyme has been implicated in prostate cancer, and we expect that it will prove relevant to other cancers as well,” says co-senior author Brooke Emerling, Ph.D., an associate professor at Sanford Burnham Prebys. “This could give us a whole new weapon against cancers that rely on this enzyme.”
Read more >>
|